Imatinib: Cost-effective in the treatment of gastrointestinal stromal tumors

被引：0
|
作者：
Finketstein, Stan N. [1 ]
Huse, Daniel M. [2 ]
Glendenning, G. A. [3 ]
Blanke, Charles D. [4 ,5 ]
Joensuu, Heikki [6 ]
von Mehren, Margaret [7 ]
Demetri, George D. [8 ]
机构：
[1] Harvard Mit Div Hlth Sci & Technol, MIT Sloan Sch Management, Cambridge, MA USA
[2] Thomson Medstat, Market Scan Studies, Cambridge, MA USA
[3] Novartis Pharmaceut, Florham Pk, NJ USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Portland Vet Med Ctr, Dept Oncol, Portland, OR USA
[6] Univ Helsinki, Dept Oncol, Helsinki, Finland
[7] Fox Chase Canc Ctr, Dept Oncol, Philadelphia, PA 19111 USA
[8] Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant, adjuvant, and palliative treatment with imatinib in patients with gastrointestinal stromal tumors.
    Nilsson, B. E.
    Sjolund, K.
    Nilsson, E. P.
    Wangberg, B.
    Nilsson, O.
    Ahlman, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors
    Saponara, Maristella
    Gatto, Lidia
    Di Nunno, Vincenzo
    Tabacchi, Elena
    Fanti, Stefano
    Di Scioscio, Valerio
    Nannini, Margherita
    Gruppioni, Elisa
    Altimari, Annalisa
    Fiorentino, Michelangelo
    Santini, Donatella
    Ceccarelli, Claudio
    Zompatori, Maurizio
    Biasco, Guido
    Pantaleo, Maria Abbondanza
    ANTI-CANCER DRUGS, 2016, 27 (04) : 353 - 363
  • [43] A long-term analysis of imatinib palliative treatment in gastrointestinal stromal tumors
    Domingues, I.
    Carvalho, J.
    Pratas, E.
    Pinheiro, S.
    Amaral, S.
    Bonito, N.
    Jesus, E.
    Ribeiro, J.
    Chaves, A.
    Pais, A.
    Sousa, G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [44] Pleomorphic phenotypes of gastrointestinal stromal tumors at metastatic sites with or without imatinib treatment
    Sakamoto, Kazuha
    Sakurai, Shinji
    Kanda, Tatsuo
    Sakuma, Yuji
    Hishima, Tsunekazu
    Hironaka, Mitsugu
    Bamba, Takeo
    Keira, Yoshiko
    Takano, Yasuo
    Niki, Toshiro
    Hasegawa, Tadashi
    Hirota, Seiichi
    CANCER SCIENCE, 2010, 101 (05): : 1270 - 1278
  • [45] Treatment of metastatic gastrointestinal stromal tumors with Imatinib.: Report of four cases
    Garrido, Marcelo S.
    Moncada, Monica M.
    Tapia, Grace N.
    Mendez, Gonzalo O.
    Galindo, Hector A.
    Huete, Alvaro G.
    Ibanez, Luis A.
    Gonzalez, Sergio
    Alvarez, Manuel Z.
    REVISTA MEDICA DE CHILE, 2007, 135 (10) : 1327 - 1332
  • [46] Approval Summary: Imatinib Mesylate in the Adjuvant Treatment of Malignant Gastrointestinal Stromal Tumors
    Cohen, Martin H.
    Cortazar, Patricia
    Justice, Robert
    Pazdur, Richard
    ONCOLOGIST, 2010, 15 (03): : 300 - 307
  • [47] Molecular correlates of imatinib resistance in gastrointestinal stromal tumors
    Heinrich, Michael C.
    Corless, Christopher L.
    Blanke, Charles D.
    Demetri, George D.
    Joensuu, Heikki
    Roberts, Peter J.
    Eisenberg, Burton L.
    von Mehren, Margaret
    Fletcher, Christopher D. M.
    Sandau, Katrin
    McDougall, Karen
    Ou, Wen-bin
    Chen, Chang-Jie
    Fletcher, Jonathan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4764 - 4774
  • [48] Complete remission with imatinib in metastatic gastrointestinal stromal tumors
    Chacón, M
    Roca, E
    Huertas, E
    Loria, FS
    Domenichini, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6801 - 6802
  • [49] Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors
    Blay, J. -Y.
    Perol, D.
    Le Cesne, A.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1659 - 1665
  • [50] Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors
    Seshadri, Ramakrishnan A.
    Rajendranath, Rejiv
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2009, 5 (04) : 267 - 271
12345